Compare Enphase Energy Inc (ENPH) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Oscar Health Inc — how do they compare? Enphase Energy Inc trades at $32.81 (market cap $4.35B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is far larger — about 2.3× Enphase Energy Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Oscar Health Inc for 15 Days on average.
| ENPH | OSCR | |
|---|---|---|
Market Cap | $4.35B | $10.22B |
Volume | 5,068,595 | 4,123,394 |
Sector | Energy | Health |
52-Week High | $72.33 | $33.81 |
52-Week Low | $26.12 | $10.85 |
Typical Hold Time | 72 Days | 15 Days |
Enterprise Value | $3.99B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.91, down 1.76% amid bearish technical signals and mixed earnings performance. The stock faces headwinds from solar sector volatility but maintains solid fundamentals with 46.95% gross margins and positive cash flow. Recent developments include IQ Meter Collar utility approvals and solid-state transformer advancements for AI data centers, providing potential growth catalysts despite recent earnings misses.
The outlook remains cautious with analyst consensus at $42.90 offering 30% upside potential, though technical indicators suggest near-term pressure. Key risks include solar industry financing challenges and competitive threats, while institutional sentiment shows modest optimism with 42% buy ratings. The stock presents a growth opportunity for investors comfortable with sector volatility and execution risks.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
